What is the Future of CAF Inhibitors in Cancer Therapy?
The future of CAF inhibitors in cancer therapy looks promising, with ongoing research aimed at overcoming current challenges. Combination therapies that include CAF inhibitors and other treatments like immune checkpoint inhibitors are being explored to enhance therapeutic outcomes. Additionally, advances in single-cell sequencing and other technologies are helping to better characterize CAFs, which could lead to more effective and targeted therapies.
